| Dr John D Dodd, OD | |
|
609 Fillmore St, Corinth, MS 38834 | |
| (662) 286-5671 | |
| (662) 287-2222 |
| Full Name | Dr John D Dodd |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 43 Years |
| Location | 609 Fillmore St, Corinth, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326121336 | NPI | - | NPPES |
| 6533 | Other | TN | UNISON DAVIS VISION |
| 6924 | Other | TN | MMC TLC |
| 00087924 | Medicaid | MS | |
| 919431 | Other | TN | UAHC VESTICA |
| P0024159 | Other | PALMETTO GBA RAILROAD | |
| 39653 | Other | TN | DAVIS VISION |
| 2230019 | Other | MS | UNITED HEALTHCARE |
| 25487 | Other | SPECTERA | |
| 3014173 | Other | TN | BCBSTN |
| 3014173 | Other | TN | TNCARE SELECT |
| 4599113 | Other | TN | MEDICAID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 501 (Mississippi) | Primary |
| 152W00000X | Optometrist | 850 (Tennessee) | Secondary |
| Provider Name | Dodd Eye Clinic P. C. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1760727481 PECOS PAC ID: 7113162348 Enrollment ID: O20130424000994 |
News Archive
Allos Therapeutics, Inc. today announced the presentation of favorable survival data from the Company's international, randomized Phase 2b investigational study of FOLOTYN relative to erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC). In this study, patients receiving FOLOTYN had a 16 percent reduction in the risk of death compared to erlotinib in the overall (intent-to-treat) population.
Kylie, Sheryl Crow, Cynthia Nixon star of Sex in the City and now the fictional character Sally from Coronation Street, what do all these women have in common? They have all faced real or portrayed public battles with breast cancer, highlighting one of the most common of the female cancers.
Cardiac injury leads to significant structural changes in the heart, including enlargement, excess formation of fibrous growth tissue, and abnormalities of the coronary vasculature. While associated factors have been targeted for therapeutic intervention, the results have been conflicting. Most studies have investigated these changes after six days of injury. However, advanced stages of remodeling have already begun by day seven following injury.
Cancer IO is a new cancer immunotherapy focused top-level collaborative research and innovation project that starts as a part of the Business Finland's Personalized Health Program.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John D Dodd, OD 609 Fillmore St, Corinth, MS 38834 Ph: (662) 286-5671 | Dr John D Dodd, OD 609 Fillmore St, Corinth, MS 38834 Ph: (662) 286-5671 |
News Archive
Allos Therapeutics, Inc. today announced the presentation of favorable survival data from the Company's international, randomized Phase 2b investigational study of FOLOTYN relative to erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC). In this study, patients receiving FOLOTYN had a 16 percent reduction in the risk of death compared to erlotinib in the overall (intent-to-treat) population.
Kylie, Sheryl Crow, Cynthia Nixon star of Sex in the City and now the fictional character Sally from Coronation Street, what do all these women have in common? They have all faced real or portrayed public battles with breast cancer, highlighting one of the most common of the female cancers.
Cardiac injury leads to significant structural changes in the heart, including enlargement, excess formation of fibrous growth tissue, and abnormalities of the coronary vasculature. While associated factors have been targeted for therapeutic intervention, the results have been conflicting. Most studies have investigated these changes after six days of injury. However, advanced stages of remodeling have already begun by day seven following injury.
Cancer IO is a new cancer immunotherapy focused top-level collaborative research and innovation project that starts as a part of the Business Finland's Personalized Health Program.
› Verified 4 days ago
Dr. Robert W Shappley, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 804 Childs St, Corinth, MS 38834 Phone: 662-286-6171 Fax: 662-287-3937 | |
Corinth Eye Clinic, Inc Optometrist Medicare: Medicare Enrolled Practice Location: 3201 Gaines Rd, Corinth, MS 38834 Phone: 662-286-8860 Fax: 662-286-3079 | |
Dr. Nixon D Dodd, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 609 N Fillmore St, Corinth, MS 38834 Phone: 662-286-5671 Fax: 662-287-2222 | |
Alcorn Eye Care Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 2301 S Harper Rd, Corinth, MS 38834 Phone: 662-287-1297 Fax: 662-286-1060 | |
John D Dodd Optometrist Medicare: Not Enrolled in Medicare Practice Location: 609 Fillmore St, Corinth, MS 38834 Phone: 662-286-5671 Fax: 662-287-2222 | |
Dr. Meredith Mccormick Rhodes, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1804 E Shiloh Rd, Corinth, MS 38834 Phone: 662-212-9001 Fax: 662-212-9004 |